Alpha 2.0
Login Register
» Articles » PMID: 7928815

The Postantibiotic Effect of RP 59500 on Staphylococcus Aureus Including Strains with a Raised MBC

Overview
Journal J Antimicrob Chemother
Publisher Oxford University Press
Specialty Infectious Diseases
Date 1994 Jun 1
PMID 7928815
Citations 5
Authors
F J Boswell
J M Andrews
R Wise
Affiliations
Soon will be listed here.
Citing Articles

Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Lamb H, Figgitt D, Faulds D Drugs. 2000; 58(6):1061-97.

PMID: 10651391 DOI: 10.2165/00003495-199958060-00008.

Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.

Pankuch G, Jacobs M, Appelbaum P Antimicrob Agents Chemother. 1998; 42(11):3028-31.

PMID: 9797249 PMC: 105989. DOI: 10.1128/AAC.42.11.3028.

Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.

Aeschlimann J, Rybak M Antimicrob Agents Chemother. 1998; 42(9):2188-92.

PMID: 9736533 PMC: 105772. DOI: 10.1128/AAC.42.9.2188.

Quinupristin-dalfopristin.

Bryson H, Spencer C Drugs. 1996; 52(3):406-15.

PMID: 8875130 DOI: 10.2165/00003495-199652030-00006.

Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.

Finch R Drugs. 1996; 51 Suppl 1:31-7.

PMID: 8724814 DOI: 10.2165/00003495-199600511-00007.